Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies.

Autor: Crombie JL; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Sherman AC; Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine and., Cheng CA; Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA; and., Ryan CE; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Zon R; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Desjardins M; Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine and.; Division of Infectious Diseases, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Baker P; Dana-Farber Cancer Institute, Boston, MA., McDonough M; Dana-Farber Cancer Institute, Boston, MA., Izaguirre N; Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine and., Bausk B; Department of Medicine and., Krauss J; Department of Medicine and., Gilboa T; Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA; and., Senussi Y; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Walt DR; Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA; and., Davids MS; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Brown JR; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Armand P; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Baden LR; Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine and., Issa N; Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine and.
Jazyk: angličtina
Zdroj: Blood advances [Blood Adv] 2021 Aug 24; Vol. 5 (16), pp. 3062-3065.
DOI: 10.1182/bloodadvances.2021005328
Databáze: MEDLINE